<DOC>
	<DOCNO>NCT02916888</DOCNO>
	<brief_summary>The purpose study investigate difference quality life patient caregiver treat general pediatrician versus pediatric dermatologist eczema ( atopic dermatitis AD ) .</brief_summary>
	<brief_title>A Study Comparing Quality Life Patients Treatment Eczema Pediatric Generalists Specialists</brief_title>
	<detailed_description>Hypothesis : We hypothesize average , patient treat general pediatrician small increase quality life end 2-week treatment period compare patient treated specialist . Methods : The primary endpoint difference patient caregiver quality life baseline group treat general pediatrician group treat pediatric dermatologist . Secondary endpoint difference atopic dermatitis severity TCS phobia baseline . Patients recruit Yale Pediatric Dermatology Clinic Long Wharf Pediatrics Adolescent Medicine New Haven , CT. Data Collection : Assessment AD investigator ( EASI ) patient/caregiver ( POEM ) complete baseline Day 0 clinic . Quality life measure ( CDLQI/IDQoL/DFI ) steroid phobia measure ( TOPICOP ) also complete Day 0 . Follow-up clinical assessment include skin examination , perform Day 14 . On follow-up visit , investigator perform assessment AD severity use EASI score method , ask patients/caregivers re-take CDLQI IDQoL , DFI , POEM TOPICOP , ask patients/caregivers report adverse effect , take digital photography utilize standard pose baseline . Patients ' medication weigh estimate amount medication use 2-week treatment period . We also instruct patient family treat subsequent AD flare similar manner first two week study , however treat clear may discontinue prior 2 week therapy . Blinding : This single-blinded study . Patients know 2 patient group treat physician , 2 group compare , know one group treat generalist specialist . Given study design , impossible blind investigator . Treatment Administration : There research treatment/procedures standard care treatment . Standard care treatment administer outpatient basis . All patient treat receive one-page handout , briefly explains AD educate family prevent atopic dermatitis outbreak . All patient also receive page explain apply corticosteroid ointment treatment AD . Patients adhere twice daily administration corticosteroid ointment 2 week , assess clearance AD . Caregivers patient document adherence home daily chart provide initial visit .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Immune System Diseases</mesh_term>
	<mesh_term>Genetic Diseases , Inborn</mesh_term>
	<mesh_term>Hypersensitivity , Immediate</mesh_term>
	<mesh_term>Skin Diseases , Eczematous</mesh_term>
	<mesh_term>Skin Diseases , Genetic</mesh_term>
	<criteria>1 . Meet clinical criterion diagnosis atopic dermatitis 2 . Have disease least 5 % total body surface area . 3 . Less 7 year age . 4 . Families able comprehend write instruction English able complete questionnaire assistance need . 5 . Parents/guardians able understand willing sign parental permission form . 1 . Clinically infected atopic dermatitis . 2 . Lack followup initial visit regimen nonadherence . 3 . Patients allergic intolerant topical medication employ study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Atopic dermatitis</keyword>
	<keyword>Topical corticosteroid</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Eczema</keyword>
	<keyword>Quality life</keyword>
</DOC>